Whalegun
Home

Myriad Genetics MYGN spent $390K on lobbying in Q1 2023 · Budget, Medicare

Trade details

Type
Lobbying report
Amount
$390,000
Quarter
Q1 2023
Stock
Myriad Genetics MYGN
Client
Myriad Genetics
Reported
23/04/19

Up 34.5% from last quarter

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Myriad Genetics's other lobbying reports

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    Under $5,000

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/18

  • Myriad Genetics

    LobbyingMyriad Genetics

    $30K

    Reported 07/17

  • Myriad Genetics

    LobbyingMyriad Genetics

    $10K

    Reported 07/03

Myriad Genetics MYGN spent $390K on lobbying in Q1 2023 · Budget, Medicare | Whalegun